Comparison of three methods for identifying medical drug-psychotropic drug interactions

被引:4
|
作者
Strain, JJ [1 ]
Chiu, NM
Brodsky, M
Karim, A
Caliendo, G
机构
[1] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA
[2] Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan
[3] Mt Sinai NYU Med Ctr Hlth Syst, Dept Neurol, Mt Sinai Sch Med, New York, NY 10029 USA
[4] Mt Sinai Hosp, Dept Pharm, New York, NY 10029 USA
关键词
D O I
10.1016/S0163-8343(02)00196-2
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Three methods for examining drug-drug interactions were compared to understand advantages and disadvantages of each: ePocrates; Interact; The Mount Sinai multiple source for the evaluation of drug-drug interactions (MS). ePocrates is a commonly employed software system utilized in a hand held computer, the PalmPilot. Interact is on a CD-ROM, and promoted by the American Psychiatric Association Press. The MS system was developed by the authors and utilizes six separate references sources to ascertain the presence and significance of drug-drug interactions. Commonly prescribed neurology and psychotropic medication interactions were compared using the three systems. ePocrates did not list the significance level of the interaction, e.g., (major, moderate, minor), often did not include a mechanism of action, and several commonly employed medications were not included. It did permit examining several drugs at the same time, and was easily carried on the person of the physician. Interact often contained old references, several drugs were not included, was not adapted to a hand held computer format, and had no update since 1999. The MS system listed level of significance, provided mechanism of action, and advice to the practitioner including recommendations. It is not portable, requiring a laptop or desk top computer or hard copy, and only searches one drug at a time. It is hoped that the advantages of each of these three systems may be incorporated into systems of the future. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:311 / 315
页数:5
相关论文
共 50 条
  • [41] Clinically Significant Psychotropic Drug-Drug Interactions in the Primary Care Setting
    English, Brett A.
    Dortch, Marcus
    Ereshefsky, Larry
    Jhee, Stanford
    CURRENT PSYCHIATRY REPORTS, 2012, 14 (04) : 376 - 390
  • [42] Patterns of psychotropic drug use in veterans with epilepsy: Do drug interactions matter?
    Gidal, Barry E.
    Rehman, Rizwana
    Tran, Tung
    Karasov, Ariela
    EPILEPSY & BEHAVIOR, 2023, 145
  • [43] Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
    Hecker, Michael
    Frahm, Niklas
    Bachmann, Paula
    Debus, Jane Louisa
    Haker, Marie-Celine
    Mashhadiakbar, Pegah
    Langhorst, Silvan Elias
    Baldt, Julia
    Streckenbach, Barbara
    Heidler, Felicita
    Zettl, Uwe Klaus
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [44] Preclinical approach for identifying drug interactions
    Tetsuya Kamataki
    Tsuyoshi Yokoi
    Ken-ichi Fujita
    Yuichi Ando
    Cancer Chemotherapy and Pharmacology, 1998, 42 : S50 - S53
  • [45] ETHANOL-PSYCHOTROPIC DRUG-INTERACTIONS - PHARMACOKINETICS
    SELLERS, EM
    PSYCHOPHARMACOLOGY BULLETIN, 1984, 20 (03) : 497 - 499
  • [46] Preclinical approach for identifying drug interactions
    Kamataki, T
    Yokoi, T
    Fujita, K
    Ando, Y
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (Suppl 1) : S50 - S53
  • [47] SIGNIFICANCE OF DRUG INTERACTIONS IN EVALUATION OF PSYCHOTROPIC-DRUGS
    BRAITHWAITE, RA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (01) : 29 - 34
  • [48] EPR STUDIES OF PSYCHOTROPIC DRUG INTERACTIONS AT CELL MEMBRANES
    SANDBERG, HE
    PIETTE, LH
    AGRESSOLOGIE, 1968, 9 (01): : 59 - &
  • [49] Psychotropic drug presentation in medical and lay press journals
    Correll, C
    Linden, M
    PHARMACOPSYCHIATRY, 2005, 38 (04) : 161 - 165
  • [50] Prevalence of Concomitant Use of Psychotropic Drugs with Severe or Major Drug-Drug Interactions in Children and Adults with Psychotropic Therapy
    Liu, Xinyue
    Castillo, Juan Hincapie
    Zhu, Yanmin
    Bussing, Regina
    Winterstein, Almut
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 334 - 334